Similar Search Results

The effect of pharmaceutical utilisation and innovation on hospitalisation and mortality

Lichtenberg, Frank R. - In: Productivity, technology and economic growth, (pp. 317-344). 2000

Persistent link: https://www.econbiz.de/10001579315

Has using newer drugs reduced admissions to hospitals and nursing homes?

Lichtenberg, Frank R. - In: Swiss journal of economics and statistics (2006), pp. 69-75

Persistent link: https://www.econbiz.de/10003377173

The impact of therapeutic procedure innovation on hospital patient longevity : evidence from Western Australia, 2000 - 2007

Lichtenberg, Frank R. - 2011

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. We investigate the effect of therapeutic procedure innovation in general on the longevity of all hospital patients, i.e. patients with a...

Persistent link: https://www.econbiz.de/10009312729

The impact of pharmaceutical innovation on longevity and medical expenditure in France : 2000 - 2009

Lichtenberg, Frank R. - In: Economics and human biology 13 (2014), pp. 107-127

Persistent link: https://www.econbiz.de/10010386634

Pharmaceutical innovation, longevity, and medical expenditure in Greece, 1995 - 2010

Lichtenberg, Frank R. - In: International journal of the economics of business 22 (2015) 2, pp. 277-299

Persistent link: https://www.econbiz.de/10011405975

The effect of pharmaceutical utilization and innovation on hospitalization and mortality

Lichtenberg, Frank R. - 1996

Persistent link: https://www.econbiz.de/10000940644

The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996-2019

Lichtenberg, Frank R. - In: Swiss journal of economics and statistics 158 (2022) 1, pp. 1-24

We analyze the association that pharmaceutical innovation had with premature mortality from all diseases in Switzerland during the period 1996-2018, and its association with hospital utilization for all diseases in Switzerland during the period 2002-2019. The analysis is performed by...

Persistent link: https://www.econbiz.de/10013177259

The health impact of, and access to, new drugs in Korea

Lichtenberg, Frank R. - In: East Asian economic review 24 (2020) 2, pp. 127-164

Persistent link: https://www.econbiz.de/10012239676

The impact of public and private research on premature cancer mortality and hospitalization in the United States, 1999-2013

Lichtenberg, Frank R. - In: The American economist : journal of Omnicron Delta … 63 (2018) 2, pp. 147-165

Persistent link: https://www.econbiz.de/10011938004

Consolidation in the medical care marketplace : a case study from Massachusetts

Barro, Jason R.; Cutler, David M. - In: Mergers and productivity, (pp. 9-42). 2000

Persistent link: https://www.econbiz.de/10001514344